Company: EUDAW
Filing Date: 2025-12-04
Form Type: 424B5
Source: 0001493152-25-026224
Chunk: 17

Company: EUDA Health Holdings Ltd
Filing Date: 2025-12-04
Form: 424B5
Chunk 17
---
 investment probable.

Our management will have broad discretion to allocate the net proceeds of this offering. Pending the application of the net proceeds for these purposes, we may invest the net proceeds in short-term, investment-grade securities.

| S-11 |

<div align='center'>DILUTION</div>

The net tangible book value of our ordinary shares as of June 30, 2025 ,was approximately $(4.0) million, or approximately $(0.10) per share. Net tangible book value per share is equal to the amount of our total tangible assets, less total liabilities, divided by the number of ordinary shares outstanding. Dilution in net tangible book value per share represents the difference between the amount per share paid by purchasers of ordinary shares in this offering and the net tangible book value per share of our ordinary shares immediately afterwards.

After deducting estimated offering expenses of approximately $82,500, our net tangible book value as of June 30, 2025 ,would have been approximately $8.03 million, or $0.20 per share. This represents an immediate increase in net tangible book value of $0.30 per share to existing stockholders and an immediate dilution of $5.80 per share to new investors purchasing ordinary shares in this offering.

| Offering price per share                                                             
 Net tangible book value per share as of June 30, 2025                                |     | (0.10 | ) |     |   | 6.00 |
|:-------------------------------------------------------------------------------------|:----|------:|:--|:----|:--|-----:|
| Increase per share attributable to new investors after giving effect to the offering |     |  0.30 |   |     |   |      |
| As adjusted net tangible book value per share after this offering                    |     |       |   |     |   | 0.20 |
| Dilution in net tangible book value per share to new investors                       |     |       |   |     | $ | 5.80 |

The calculations above are based on 37,807,491 ordinary shares issued and outstanding as of December 4, 2025, exclude the following:

| ● | Up                                                                                                                                   
 to 2,000,000 of our ordinary shares issuable upon exercise of the Warrant.                                                           |
| ● | 37,516 of our ordinary shares issuable upon conversion                                                                               
 of convertible notes in the aggregate principal amount of $53,402 as of December 4, 2025 at